MedPath

Study comparing the effects of 0.75% Ropivacaine heavy and 0.5% Bupivacaine heavy in intrathecal injections during elective procedures

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2023/08/056690
Lead Sponsor
Others
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

study will be done on eighty cases of either sex of ASA class-I or II between age group of 18-60 years weighing between 50-70kgs and height 160-170 cms scheduled for elective surgeries

Exclusion Criteria

Any h/o respiratory, cardiac, hepatic or renal disease, convulsions

Patients with h/o bleeding disorder

local infection at the site of injection

H/o allergy to local anesthetic agent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Onset of sensory block <br/ ><br>Duration of sensory block <br/ ><br>onset of motor block <br/ ><br>duration of motor blockTimepoint: Baseline, 2 minutes, 4 minutes, 6 minutes, 8 minutes
Secondary Outcome Measures
NameTimeMethod
incidence of urinary retention, anaphylaxis, postoperative nausea and vomitingTimepoint: 06 hours, 12 hours, 24 hours
© Copyright 2025. All Rights Reserved by MedPath